Charles Schwab’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.3K | Sell |
163,377
-107,443
| -40% | -$60K | ﹤0.01% | 3419 |
|
|
2025
Q1 | $129K | Sell |
270,820
-86,985
| -24% | -$41.4K | ﹤0.01% | 3310 |
|
|
2024
Q4 | $361K | Buy |
357,805
+2,474
| +0.7% | +$2.5K | ﹤0.01% | 3233 |
|
|
2024
Q3 | $608K | Sell |
355,331
-43,049
| -11% | -$73.6K | ﹤0.01% | 3093 |
|
|
2024
Q2 | $1.02M | Buy |
398,380
+246,329
| +162% | +$628K | ﹤0.01% | 2931 |
|
|
2024
Q1 | $636K | Buy |
152,051
+3,290
| +2% | +$13.8K | ﹤0.01% | 2936 |
|
|
2023
Q4 | $494K | Buy |
148,761
+1,960
| +1% | +$6.51K | ﹤0.01% | 3076 |
|
|
2023
Q3 | $294K | Sell |
146,801
-13,257
| -8% | -$26.5K | ﹤0.01% | 3218 |
|
|
2023
Q2 | $506K | Buy |
160,058
+8,271
| +5% | +$26.1K | ﹤0.01% | 3048 |
|
|
2023
Q1 | $527K | Sell |
151,787
-1,536
| -1% | -$5.33K | ﹤0.01% | 2930 |
|
|
2022
Q4 | $787K | Buy |
153,323
+2,976
| +2% | +$15.3K | ﹤0.01% | 2860 |
|
|
2022
Q3 | $1.49M | Buy |
150,347
+55,616
| +59% | +$550K | ﹤0.01% | 2667 |
|
|
2022
Q2 | $796K | Buy |
94,731
+3,549
| +4% | +$29.8K | ﹤0.01% | 2881 |
|
|
2022
Q1 | $1.15M | Buy |
91,182
+13,681
| +18% | +$172K | ﹤0.01% | 2800 |
|
|
2021
Q4 | $1.23M | Buy |
77,501
+2,425
| +3% | +$38.5K | ﹤0.01% | 2831 |
|
|
2021
Q3 | $1.89M | Buy |
+75,076
| New | +$1.89M | ﹤0.01% | 2711 |
|